AMPH (Amphastar Pharmaceuticals Inc) Gross Profit Rate

Corporate emblem and logo of Amphastar Pharmaceuticals Inc (AMPH)

Amphastar Pharmaceuticals (AMPH) is demonstrating steady commercial growth across its injectable product lines. Analyzing the chart on GURU.Markets, we find that the aggregate gross margin is holding at 44.70. This is based on the company's leadership in the emergency generics sector for the B2B market. High efficiency is achieved through the sale of specialized respiratory therapy drugs and medical consumables.

Amphastar Pharmaceuticals, Inc. (AMPH) Gross Profitability: for the period 07/04/2022 - 11/20/2026

Financial and market metric breakdowns for Amphastar Corp (AMPH)

Basic company analysis:Amphastar (AMPH)
Flagship merchandise of Amphastar

The complexity of producing generic inhalers and stringent FDA oversight provide Amphastar Pharmaceuticals (AMPH) with high market resilience. The company's gross margin reflects the profit share after deducting direct production costs, allowing investors to assess the efficiency of raw material cost management. Monitoring this metric helps detect hidden profitability erosion in advance and prevents overpaying for the asset when analyzing the company's gross margin.

Key competitors

Gross Profit Margin Haleon PLC (HLN)|Return on Gross Profit KVUE|Gross Profit Margin Verona Pharma Inc. VRNA|Gross Margin MENS|Ligand Pharmaceuticals - Gross Return on Sales|Gross Profitability Amneal AMRX|Gross Sales Margin Perrigo Company PLC|Alvotech Biopharmaceuticals - Gross Margin|Return on Sales by Gross Profit Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Gross Profitability|anipharmaceuticals.com - Gross Profit Rate|Return on Gross Profit MNKD|Pacira Pharmaceuticals (PCRX) - Return on Sales by Gross Profit|Gross Margin SPRY|TBPH - Gross Profit Margin|Aquestive Pharma - Return on Gross Profit|Gross Margin scpharmaceuticals.com SCPH|Tectonic - Gross Margin|TNXP - Gross Margin|SXTC: Gross Margin|Eupraxia Pharma - Gross Profit Rate|BHST (bioharvest.com) - Gross Margin|Gross Return on Sales EXOZ (invizyne.com)|Gross Margin ORMP|Return on Sales by Gross Profit Entera Bio|Gross Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Gross Profitability|Cumberland Corp - Gross Margin|QNTM - Gross Margin|FibroGen, Inc. (FGEN) - Gross Profitability|TELO: Gross Profit Ratio|RANI (Rani Therapeutics Inc) - Gross Margin|Gross Profit Margin synergychc.com SNYR|Gross Profitability Rallybio Corp. (RLYB)|LEXX - Gross Profit Margin|Gross Margin PULM (pulmatrix.com)|Gross Profit Ratio PTHL (Pheton)|APM - Gross Profitability|Return on Sales by Gross Profit Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Gross Profitability|TNF Pharma (TNFA) - Gross Margin|YCBD (cbdmd.com) - Gross Margin|Return on Gross Profit PainReform (PRFX)|Gross Profitability Altamira Therapeutics (CYTO)|Return on Sales by Gross Profit Lipella Pharma|Optinose - Return on Gross Profit|Return on Sales by Gross Profit pieris.com (PIRS)|PROC - Gross Profitability|Gross Profitability Margin PTPI|QLI: Gross Margin|Gross Profit Margin ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Gross Margin